Collectively, these insights position chemerin as a regulator that exerts context-dependent effects in experimental IBD: harmful when it obstructs macrophage-mediated inflammation resolution, but beneficial when it supports epithelial antimicrobial activity and microbial stability. This evidence concerns the gene RARRES2 and inflammatory bowel disease.